首页> 外文期刊>Palliative medicine >The impact of therapeutic opioid agonists on driving-related psychomotor skills assessed by a driving simulator or an on-road driving task: A systematic review
【24h】

The impact of therapeutic opioid agonists on driving-related psychomotor skills assessed by a driving simulator or an on-road driving task: A systematic review

机译:治疗性阿片类激动剂对驾驶模拟器或通道驾驶任务评估的驾驶相关精神仪技能的影响:系统评价

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Driving cessation is associated with poor health-related outcomes. People with chronic diseases are often prescribed long-term opioid agonists that have the potential to impair driving. Studies evaluating the impact of opioids on driving-related psychomotor skills report contradictory results likely due to heterogeneous designs, assessment tools and study populations. A better understanding of the effects of regular therapeutic opioid agonists on driving can help to inform the balance between individual’s independence and community safety. Aim: To identify the literature assessing the impact of regular therapeutic opioid agonists on driving-related psychomotor skills for people with chronic pain or chronic breathlessness. Design: Systematic review reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-analysis statement; PROSPERO Registration CRD42017055909. Data sources: Six electronic databases and grey literature were systematically searched up to January, 2017. Inclusion criteria were as follows: (1) empirical studies reporting data on driving simulation, on-the-road driving tasks or driving outcomes; (2) people with chronic pain or chronic breathlessness; and (3) taking regular therapeutic opioid agonists. Critical appraisal used the National Institutes of Health’s quality assessment tools. Results: From 3809 records screened, three studies matched the inclusion criteria. All reported data on people with chronic non-malignant pain. No significant impact of regular therapeutic opioid agonists on people’s driving-related psychomotor skills was reported. One study reported more intense pain significantly worsened driving performance. Conclusion: This systematic review does not identify impaired simulated driving performance when people take regular therapeutic opioid agonists for symptom control, although more prospective studies are needed.
机译:背景:驾驶停止与健康相关结果不佳。患有慢性疾病的人通常规定长期阿片类药剂,有可能损害驾驶。研究评估阿片类药物对驾驶相关的精神运动技能的影响报告矛盾的结果可能由于异质设计,评估工具和研究人口而可能。更好地理解常规治疗阿片激动剂对驾驶的影响可以有助于向个人独立和社区安全之间的平衡提供信息。目的:鉴定常规治疗阿片类激动剂对慢性疼痛或慢性呼吸困难的驾驶相关精神仪技能的影响的文献。设计:根据首选报告项目报告系统审查,用于系统审查和META分析声明; Prospero注册CRD42017055909。数据来源:六个电子数据库和灰色文献系统地搜索了2017年1月。纳入标准如下:(1)报告关于驾驶模拟,路上驾驶任务或驾驶结果的数据的实证研究; (2)患有慢性疼痛或慢性呼吸困难的人; (3)采用常规治疗阿片类毒剂。批判性评估使用了国家卫生研究院的质量评估工具。结果:从3809次筛选的记录,三项研究符合纳入标准。所有关于患有慢性非恶性疼痛的人的数据。据报道,常规治疗阿片类药物对人们驾驶相关的精神电脑技能没有重大影响。一项研究报告了更强烈的疼痛显着恶化了驾驶性能。结论:当人们采取常规治疗阿片激动剂进行症状控制时,这种系统审查不会识别模拟驾驶性能受损,尽管需要更多的前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号